Results for tag: "Thyroid Cancer Diagnostics"

The Thyroid Cancer Diagnostics market encompasses a range of medical tests and procedures used to identify and characterize thyroid malignancies. Thyroid cancer is a form of cancer that originates in the thyroid gland, which is located in the neck and participates in regulating metabolism through hormone release. Diagnostics for this disease typically begin with a physical examination and continue with various imaging tests such as ultrasound, which is commonly employed to visualize the thyroid for any irregularities. Additional diagnostic techniques may involve blood tests to assess thyroid function and levels of thyroid-related hormones and proteins. More definitive diagnosis often requires a biopsy, where a sample of thyroid tissue is collected for microscopic examination. Fine needle aspiration cytology (FNAC) is commonly used for this purpose as it is minimally invasive and provides sufficient cells for cytological evaluation. Patients who are diagnosed with thyroid cancer may undergo further diagnostic testing to determine the cancer's stage and form, which includes genetic testing to identify specific mutations and molecular markers. These diagnostics are crucial for guiding treatment decisions and for prognostication. In the Thyroid Cancer Diagnostics market, a number of specialized companies provide various testing products and services. Some of these include Myriad Genetics, which offers molecular tests for genetic predisposition and cancer characterization; Veracyte, known for its genomic testing solutions; Agilent Technologies, which provides a range of analytical instruments, software, services, and consumables for diagnostic testing; and Thermo Fisher Scientific, an industry leader offering an array of laboratory equipment and assays for medical diagnostics Show Less Read more